Pharmaceuticals Market Research Reports & Industry Analysis
The global pharmaceutical industry is a vital part of the healthcare landscape—affecting everyone, from patients seeking treatment to healthcare providers looking for the latest advances in medicine. That's why MarketResearch.com offers a wide range of pharmaceutical reports, providing critical insights into market trends, industry challenges, and emerging opportunities.
What’s Inside Our Pharmaceutical Industry Reports
- We cover an extensive range of segments within the pharmaceutical industry, including biopharmaceuticals, clinical trials, dietary supplements, drug discovery, manufacturing & packaging, over-the-counter drugs, prescription drugs, research & development, vaccines, and more.
- Our research offers valuable information on the market landscape, key factors driving change, company and product profiles, and regulatory analysis.
- We also cover disruptive trends, such as gene editing, precision medicine, and artificial intelligence, ensuring our clients stay ahead of market changes.
MarketResearch.com: A Reliable Source for Critical Data
At MarketResearch.com, we understand the importance of reliable and comprehensive research. For over 20 years, we have been a leading company in the field of market research, bringing together reports from hundreds of leading firms in one place for convenient access.
View recent articles on this industry on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
Global Prefilled Syringes Market to Achieve Unprecedented Growth by 2035
Global Medical Aesthetic Market to Surge to $102.2 Billion by 2035
Cancer Biomarker Market Size to Reach $39.7 Billion by 2028
Additional articles on this industry
Pharmaceuticals Industry Research & Market Reports
-
Animal Antibiotics and Antimicrobials
... reach US$7.0 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Tetracycline, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.6 ... Read More
-
Genitourinary Drugs
... at a CAGR of 2.4% over the analysis period 2023-2030. Urologicals, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$10.7 Billion by the end of the ... Read More
-
Orthopedic Digit Implants
... by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Titanium Material, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$139.3 Million by ... Read More
-
Intravaginal Insemination
... at a CAGR of 7.3% over the analysis period 2023-2030. The U.S. Market is Estimated at US$123.9 Million While China is Forecast to Grow at 10.7% CAGR The Intravaginal Insemination market in the U.S. is ... Read More
-
Ocular Prosthesis
... at a CAGR of 6.5% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Produce Packaging Trays
... by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Growers / Shippers End-Use, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.0 ... Read More
-
Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living with HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029
... The latent TB testing market will rise in value from estimated USD 582.5 million in 2024 to USD 773.4 million in 2029, at a CAGR of 5.8% over the forecast period. Increased funding and grants ... Read More
-
Global Biosimilars Market (2nd Edition)
... has experienced significant growth, owing to its improved effectiveness in managing chronic diseases. However, the high costs associated with biologics pose considerable economic and healthcare challenges. As the demand for biologics continues to increase, developers ... Read More
-
Pre-Eclampsia - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Pre-Eclampsia: Understanding ... Read More
-
Schizophrenia - Pipeline Insight, 2024
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Schizophrenia: Understanding Schizophrenia: ... Read More
-
Global Electric Cannabis Grinder Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 2066 million by 2030 with a CAGR of 7.2% during review period. Legalization of cannabis in several countries over past few years have ... Read More
-
Global Oral Rehydration Solution Market Research Report 2024
... of 5.34% during the forecast period 2024-2030. North American market for Oral Rehydration Solution is estimated to increase from $ 275.7 million in 2023 to reach $ 384.35 million by 2030, at a CAGR of ... Read More
-
Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Report, History and Forecast 2019-2030
... reach $ 780.46 million by 2030, at a CAGR of 3.64% during the forecast period of 2024 through 2030. North American market for Chlorhexidine Gluconate Product for Patient Skin Antisepsis was valued at $ 217.01 ... Read More
-
Impact of Covid-19 on Pharmaceuticals Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... of Covid-19 on the pharmaceuticals market size was valued at USD 1,494.67 billion in 2021, and the market is now projected to grow from USD 1,585.05 billion in 2022 to USD 2,401.22 billion by 2029, ... Read More
-
Global Musculoskeletal System Disorder Market Research Report 2024
... of 4.19% during the forecast period 2024-2030. North American market for Musculoskeletal System Disorder is estimated to increase from $ 77023 million in 2023 to reach $ 100034 million by 2030, at a CAGR of ... Read More
-
Glaucoma Therapeutics
... at a CAGR of 3.5% over the analysis period 2023-2030. Prostaglandins Analogs, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Implantable Drug Delivery Devices
... reach US$41.2 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Contraceptive Implants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach ... Read More
-
IoT in Intelligent Transportation System
... is expected to reach US$543.4 Billion by 2030, growing at a CAGR of 20.0% over the analysis period 2023-2030. Hardware Component, one of the segments analyzed in the report, is expected to record a 21.7% ... Read More
-
Label-free Array Systems
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Surface Plasmon Resonance (SPR) Technology, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach ... Read More
-
Preclinical Contract Research Organizations
... reach US$11.3 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Toxicology Testing Service, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and ... Read More
-
Respiratory Protection Equipment
... by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Air Purifying Respirators, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$15.3 Billion ... Read More
-
Therapeutic Respiratory Devices
... by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$32.3 ... Read More
-
Hereditary Angioedema
... at a CAGR of 7.7% over the analysis period 2023-2030. C1 Esterase Inhibitors, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.5 Billion by the end ... Read More
-
Motion Sickness Treatment
... by 2030, growing at a CAGR of 1.9% over the analysis period 2023-2030. Anticholinergic Treatment, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$532.7 Million by ... Read More
-
Office Administrative Services
... by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Administrative Management Services, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$62.1 Billion ... Read More
Research Assistance
